← Back to Search

Behavioral Intervention

Early Intervention Programs for Parenting Neglected Children

Phase 1 & 2
Waitlist Available
Led By Mary Dozier, Ph.D.
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
must have been in earlier randomized clinical trial
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up child age of 10 years
Awards & highlights

Study Summary

This trial will compare the outcomes of two groups of neglecting parents, one of which received an intervention in infancy. It is expected that the intervention group will be more nurturing and follow their children's lead more, and that the children will have better outcomes in various areas than the control group.

Who is the study for?
This trial is for children who have been diagnosed with Conduct Disorder, ADHD, or Depression and were part of an earlier clinical trial. It focuses on the long-term effects of a parenting intervention given during infancy.Check my eligibility
What is being tested?
The study tests if early childhood interventions like Developmental Education for Families and Attachment and Biobehavioral Catch-up can lead to better nurturing by parents and improved child outcomes in areas such as attachment, self-control, emotion management, and social interactions.See study design
What are the potential side effects?
Since this trial involves educational and behavioral interventions rather than medications, traditional side effects are not expected. However, there may be emotional or psychological impacts from participating in the therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~child age of 10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and child age of 10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attachment
Child aggression
Child diagnosis
+4 more
Secondary outcome measures
Alpha and theta wave
Autonomic nervous system activity
Body mass index
+9 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Attachment and Biobehavioral Catch-upExperimental Treatment1 Intervention
Attachment and Biobehavioral Catch-up - 10 session intervention to enhance nurturance and following the lead
Group II: Developmental Education for FamiliesActive Control1 Intervention
Developmental Education for Families - 10 session intervention that targets cognitive development
Group III: Low-riskActive Control1 Intervention
Low-risk comparison group
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Attachment and Biobehavioral Catch-up
2002
Completed Phase 1
~440

Find a Location

Who is running the clinical trial?

University of DelawareLead Sponsor
154 Previous Clinical Trials
24,991 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
220 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Mary Dozier, Ph.D.Principal InvestigatorUniversity of Delaware
4 Previous Clinical Trials
760 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
220 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)

Media Library

Attachment and Biobehavioral Catch-up (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT02093052 — Phase 1 & 2
Attention Deficit Hyperactivity Disorder (ADHD) Research Study Groups: Developmental Education for Families, Low-risk, Attachment and Biobehavioral Catch-up
Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial 2023: Attachment and Biobehavioral Catch-up Highlights & Side Effects. Trial Name: NCT02093052 — Phase 1 & 2
Attachment and Biobehavioral Catch-up (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02093052 — Phase 1 & 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial limited to persons over a certain age, or can individuals of all ages participate?

"As per the study's requirements, only children aged 6 to 8 can participate."

Answered by AI

What is the primary focus of this research endeavor?

"This clinical trial will span 36 months and is designed to track changes in Child aggression. The secondary goals are Autonomic nervous system activity (Respiratory Sinus Arrhythmia), brain activation as observed through fMRI, and Play group interactions which will be analyzed for indices of peer rejection."

Answered by AI

Is this trial still accepting new participants?

"According to clinicaltrials.gov, this research is not currently accepting participants. It was first posted on March 1st 2005 and last updated November 14th 2020. Despite this, 1271 other studies are actively seeking volunteers right now."

Answered by AI

Who has the opportunity to participate in this research?

"This trial is recruiting 220 minors aged 6 and 8, who suffer from conduct disorder. Critically, prospects should have participated in a previous randomized clinical experiment."

Answered by AI
Recent research and studies
~11 spots leftby Apr 2025